Search
GT Biopharma Inc
GTBPAdd to Watchlist
0.290USD
-0.018-5.69%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.76MMarket Cap
LossP/E TTM
GT Biopharma Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of GT Biopharma Inc is 6.85, ranking 250 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.05, which is -79.06% below the recent high of -0.01 and -3189.94% above the recent low of -1.60.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.